A team of Creighton researchers has earned a National Institutes of Health grant to study drug therapy in the treatment of Parkinson’s disease. Shashank Dravid, PhD, an associate professor in Creighton’s Department of Pharmacology, is the lead investigator on the grant, with a research group comprising Gajanan Shelkar, PhD, a post-doctoral researcher; Jinxu Liu, a research associate; Ratnamala Pavuluri, research technician; and a graduate student, Pauravi Gandhi.
A team of Creighton University researchers in the School of Medicine’s Department of Pharmacology has earned a National Institutes of Health grant to help people experiencing the gross motor dysfunction in Parkinson’s disease.
Creighton University designs its forthcoming 28-month PA program to “transform you into an exemplary health care provider."
A team of Creighton researchers has earned a National Institutes of Health grant to study drug therapy in the treatment of Parkinson’s disease. Shashank Dravid, PhD, an associate professor in Creighton’s Department of Pharmacology, is the lead investigator on the grant, with a research group comprising Gajanan Shelkar, PhD, a post-doctoral researcher; Jinxu Liu, a research associate; Ratnamala Pavuluri, research technician; and a graduate student, Pauravi Gandhi.